You are here

Amgen

Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents

Yahoo/Benzinga

Wed, 05/3/23 - 10:41 pm

As Amgen's revenues slide, so too do sales at its big buyout target Horizon

Fierce Pharma

Wed, 05/3/23 - 10:29 pm

Horizon Therapeutics

Chronic hives: Four major clinical trials to watch in 2023

Clinical Trials Arena

Wed, 05/3/23 - 11:53 am

chronic urticaria

clinical trials

Celldex Therapeutics

Amgen cuts lupus programs for futility, hours after Lilly officially walks away from one too

Fierce Biotech

Fri, 04/28/23 - 10:46 am

Q1 revenues slide for Amgen, Gilead

Medical Marketing and Media

Thu, 04/27/23 - 10:54 pm

Gilead Sciences

Activist shareholders ask 9 big pharmas to consider whether 'excessive' patenting hurts access

Fierce Pharma

Wed, 04/26/23 - 05:50 pm

Bristol Myers Squibb

Gilead Sceinces

Amgen faces patent infringement claims on big-selling osteoporosis drug Evenity

Fierce Pharma

Tue, 04/25/23 - 10:10 pm

Drugmakers take sides in Amgen, Regeneron fight over antibody patents

BioPharma Dive

Mon, 04/24/23 - 10:17 am

Regeneron Pharmaceuticals

Finding the big spenders beyond big pharma

EP Vantage

Mon, 04/24/23 - 10:15 am

Gilead Sciences

Moderna Therapeutics

Regeneron Pharmaceuticals

Vertex Pharmaceuticals

Big pharma holds steady on research spending

EP Vantage

Fri, 04/21/23 - 10:03 am

Amgen nabs appeals win against Otezla generics, blocking Sandoz and Zydus copycats until 2028

Fierce Pharma

Thu, 04/20/23 - 11:47 am

AACR: Lilly challenges Amgen, Mirati with early KRAS data, heading for a field 'much less crowded than it seems'

Fierce Biotech

Tue, 04/18/23 - 10:18 pm

Mirati Therapeutics

KRAS inhibitors

Biotech layoffs gather pace as industry downturn persists

BioPharma Dive

Tue, 04/11/23 - 07:18 pm

Jounce Therapeutics

Fate Therapeutics

Molecular Templates

Sorrento Therapeutics

After 2022's M&A spree, Amgen CEO Bradway collects $21.4M payday

Fierce Pharma

Mon, 04/10/23 - 05:06 pm

executive compensation

Amgen's denosumab shows promise in small, NIH-funded rare bone disease study

Endpoints

Wed, 04/5/23 - 07:15 pm

clinical trials

monoclonal antibodies

Acquired patents aid J&J defense of top-selling drug from biosimilar challenge

BioPharma Dive

Wed, 03/29/23 - 03:56 pm

AstraZeneca, Amgen's asthma launch Tezspire picks up backing from England's NICE

Fierce Pharma

Wed, 03/29/23 - 09:58 am

Amgen cites inflation, pressure on drug prices in 450-person layoff

Endpoints

Fri, 03/17/23 - 09:59 am

Amgen is sued for concealing $10.7 billion tax bill from investors

Reuters

Wed, 03/15/23 - 11:11 am

Armed with $60M series A and Lilly's backing, Volastra enters clinic via Amgen cancer med

Fierce Biotech

Tue, 03/7/23 - 11:45 am

Volastra Therapeutics

Pages